Cited by 204Advanced Glycation End Products researchRetinal Diseases and TreatmentsAldose Reductase and Taurine

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

Open access
Xu, Jing, Chen, Lin-Jiang, Yu, Jian, Wang, Han-Jing, Zhang, Fan, Liu, Qiong, Wu, Jing·2018·Cellular Physiology and Biochemistry

Abstract

Diabetic retinopathy (DR) is a common and devastating microvascular complication of diabetes and a major cause of acquired blindness in young adults. Advanced glycation end products (AGEs) accumulated under hyperglycemic conditions are thought to play an important role in the pathogenesis of DR. AGEs can exert their deleterious effects by acting directly to induce aberrant crosslinking of extracellular matrix proteins, to increase vascular stiffness, altering vascular structure and function. Moreover, AGEs binding to the receptor for AGEs (RAGE) evokes intensive intracellular signaling cascades that leading to endothelial dysfunction, elaboration of key proinflammatory cytokines and proangiogenic factors, mediating pericyte apoptosis, vascular inflammation and angiogenesis, as well as breakdown of the inner blood-retinal barrier (BRB), the end result of all these events is damage to the neural and vascular components of the retina. Elucidation of AGE-induced mechanisms will help in the understanding of the complex cellular and molecular pathogenesis associated with DR. Novel anti-AGEs agents or AGE crosslink “breakers” are being investigated, it is hoped that in next few years, some of these promising therapies will be successfully applied in clinical context, aiming to reduce the major economical and medical burden caused by DR.

Integrity signals

Registry

Crossref · 10.1159/000491897

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J.
Affiliations
Nanfang Hospital (CN)
Venue
Cellular Physiology and Biochemistry
Publisher
S. Karger AG
Published
2018
Volume
48
Issue
2
Pages
705-717
ISSN
  • 1015-8987 (ISSN-L)
  • 1421-9778
OpenAlex
W2883415922
Cited by
204
References
73
Citations by year
2026: 13 · 2025: 28 · 2024: 21 · 2023: 28 · 2022: 35 · 2021: 33 · 2020: 31 · 2019: 14 · 2018: 1
FWCI
15.34
Type
journal article
Language
en
Open access
Locations
  • Cellular Physiology and Biochemistry (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Science and Technology Planning Project of Guangdong Province
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
Keywords
diabetic retinopathy, advanced glycation end products, receptor for advanced glycation end products, hyperglycemia, extracellular matrix cross-linking, vascular stiffness, endothelial dysfunction, pericyte apoptosis, angiogenesis, vascular inflammation, blood-retinal barrier breakdown, retinal microvascular complications
MeSH terms
Receptor for Advanced Glycation End Products, Blood-Retinal Barrier, Diabetic Retinopathy, Humans, Glycation End Products, Advanced, Reactive Oxygen Species, Vascular Endothelial Growth Factor A, Endoplasmic Reticulum Stress, Tight Junction Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review